Search Within

Gregory J Riely

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
Groups
  1. Center for Molecular Imaging and Biotechnology (14)
  2. Department of Medicine (14)
  3. GSK Faculty (14)
  4. Solid Tumor Oncology Division (14)
  5. Thoracic Oncology (14)
  6. Human Oncology and Pathogenesis Program (12)

More Groups

People
  1. Charles Rudin (11)
  2. Marc Ladanyi (9)
  3. Mark Kris (9)
  4. Romel Somwar (7)
  5. Alexander Drilon (6)
  6. Camelia Sima (5)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Journal of Thoracic Oncology (3)
  3. Annals of Oncology (2)
  4. Cancer Discovery (1)
  5. Clinical Lung Cancer (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Inc. (4)
  3. Oxford University Press (2)
  4. American Association for Cancer Research (1)
  5. American Medical Association (1)
  6. Elsevier Science, Inc. (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Implications of selection bias due to delayed study entry in clinical genomic studies
    Journal Article

    Brown, S.; Lavery, J. A.; Shen, R.; Martin, A. S.; Kehl, K. L.; Sweeney, S. M.; Lepisto, E. M.; Rizvi, H.; McCarthy, C. G.; Schultz, N.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Progression-free survival estimates in non-small cell lung cancer when RECIST is unavailable: Project GENIE's integration of genomic, therapeutic and phenomic data
    Meeting Abstract

    Lavery, J. A.; Panageas, K.; LeNoue-Newton, M.; Sweeney, S.; Sheffler-Collins, S.; Rudolph, J. E.; Rizvi, H.; Schultz, N.; Lepisto, E. M.; Kehl, K. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Journal Article

    Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Acquired BRAF fusions as a mechanism of resistance to EGFR therapy
    Meeting Abstract

    Vojnic, M.; Kurzatkowski, C.; Kubota, D.; Suzawa, K.; Liu, Z.; Mattar, M.; Khodos, I.; Poirier, J. T.; de Stanchina, E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers
    Journal Article

    Yu, H. A.; Sima, C.; Feldman, D.; Liu, L. L.; Vaitheesvaran, B.; Cross, J.; Rudin, C. M.; Kris, M. G.; Pao, W.; Michor, F.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save